Side Effects From Chemo Can Be Devastating. This Startup Aims To Change That.

Shasqi is the first of 300 healthcare companies backed by Y Combinator to start clinical trials in humans, with a plan to make chemo a better experience with more targeted therapy.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive